Citadel Advisors’s Enlivex Ltd ENLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$26K Buy
1,864
+158
+9% +$2.5K ﹤0.01% 12616
2025
Q4
$18K Sell
1,706
-2,890
-63% -$43.1K ﹤0.01% 12363
2025
Q3
$71.7K Buy
+4,596
New +$82.8K ﹤0.01% 12023
2025
Q2
Sell
-4,676
Closed -$69.5K 13172
2025
Q1
$68K Buy
+4,676
New +$77.7K ﹤0.01% 11955
2024
Q2
Sell
-3,702
Closed -$98.3K 14521
2024
Q1
$210K Buy
3,702
+3,230
+684% +$158K ﹤0.01% 10211
2023
Q4
$19.1K Sell
472
-2,040
-81% -$52K ﹤0.01% 12654
2023
Q3
$59.5K Sell
2,512
-62
-2% -$2.15K ﹤0.01% 11549
2023
Q2
$102K Sell
2,574
-724
-22% -$30.2K ﹤0.01% 10909
2023
Q1
$180K Sell
3,298
-671
-17% -$40.4K ﹤0.01% 10360
2022
Q4
$232K Buy
3,969
+1,332
+51% +$85.9K ﹤0.01% 9833
2022
Q3
$168K Buy
+2,637
New +$193K ﹤0.01% 10591
2021
Q1
Sell
-722
Closed -$149K 13275
2020
Q4
$91K Buy
+722
New +$116K ﹤0.01% 10275
2017
Q2
Sell
-38
Closed -$17K 7608
2017
Q1
$17K Buy
+38
New +$25K ﹤0.01% 7286
2016
Q4
Sell
-19
Closed -$19K 7374
2016
Q3
$19K Buy
+19
New +$19.3K ﹤0.01% 7066

Other funds holding ENLV

Citadel Advisors's ENLV Position: Q1 2026 in Review

Citadel Advisors increased its Enlivex Ltd (ENLV) stake by 9.3% in Q1 2026, buying an estimated $2.5K and bringing the position to 1,864 shares worth $26K. The position accounts for ﹤0.01% of the portfolio, ranked #12616.

Citadel Advisors first reported a position in ENLV in Q3 2016 and has held it in 14 quarters since. The position peaked at $232K in Q4 2022. 34 funds tracked by Wall St. Rank hold ENLV as of Q1 2026.

  • Citadel Advisors held 1,864 shares of Enlivex Ltd worth $26K as of Q1 2026.
  • Citadel Advisors bought 158 Enlivex Ltd shares in Q1 2026, an estimated $2.5K.
  • Enlivex Ltd made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #12616 holding.
  • Citadel Advisors first reported a position in Enlivex Ltd in Q3 2016 and has held it in 14 quarters since.
  • Citadel Advisors's Enlivex Ltd position peaked at $232K in Q4 2022.
  • 34 funds tracked by Wall St. Rank held Enlivex Ltd as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.